Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.

COVID-19 Health care settings Healthcare workers NHS Pandemic Semi-structured interviews Testing UK health policy

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
24 06 2021
Historique:
received: 23 04 2021
accepted: 10 06 2021
entrez: 25 6 2021
pubmed: 26 6 2021
medline: 1 7 2021
Statut: epublish

Résumé

As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 testing policies and practices; and to inform future pandemic diagnostic preparedness. A remote qualitative, semi-structured longitudinal interview method was employed with a purposive snowball sample of senior scientific advisors to the UK Government on COVID-19, and HCWs employed in NHS primary and secondary health care settings in England. Twenty-four interviews from 13 participants were selected from the larger project dataset using a key term search, as not all of the transcripts contained references to testing. Framework analysis was informed by the non-adoption, abandonment, scale-up, spread, and sustainability of patient-facing health and care technologies implementation framework (NASSS) and by normalisation process theory (NPT). Our account highlights tensions between the communication and implementation of national testing developments; scientific advisor and HCW perceptions about infectiousness; and uncertainties about the responsibility for testing and its implications at the local level. Consideration must be given to the implications of mass NHS staff testing, including the accuracy of information communicated to HCWs; how HCWs interpret, manage, and act on testing guidance; and the influence these have on health care organisations and services.

Sections du résumé

BACKGROUND
As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 testing policies and practices; and to inform future pandemic diagnostic preparedness.
METHODS
A remote qualitative, semi-structured longitudinal interview method was employed with a purposive snowball sample of senior scientific advisors to the UK Government on COVID-19, and HCWs employed in NHS primary and secondary health care settings in England. Twenty-four interviews from 13 participants were selected from the larger project dataset using a key term search, as not all of the transcripts contained references to testing. Framework analysis was informed by the non-adoption, abandonment, scale-up, spread, and sustainability of patient-facing health and care technologies implementation framework (NASSS) and by normalisation process theory (NPT).
RESULTS
Our account highlights tensions between the communication and implementation of national testing developments; scientific advisor and HCW perceptions about infectiousness; and uncertainties about the responsibility for testing and its implications at the local level.
CONCLUSIONS
Consideration must be given to the implications of mass NHS staff testing, including the accuracy of information communicated to HCWs; how HCWs interpret, manage, and act on testing guidance; and the influence these have on health care organisations and services.

Identifiants

pubmed: 34167491
doi: 10.1186/s12889-021-11285-8
pii: 10.1186/s12889-021-11285-8
pmc: PMC8224254
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216

Subventions

Organisme : Medical Research Council
ID : MC_PC_19069
Pays : United Kingdom

Références

Policy Sci. 2020 Apr 18;:1-17
pubmed: 32313308
Health Econ Policy Law. 2020 Aug 19;:1-8
pubmed: 32811590
BMJ Glob Health. 2019 Jan 29;4(Suppl 2):e001179
pubmed: 30815287
PLoS One. 2020 Dec 10;15(12):e0242958
pubmed: 33301459
J Med Internet Res. 2017 Nov 01;19(11):e367
pubmed: 29092808
Int J Ment Health Addict. 2021 Jan 7;:1-10
pubmed: 33437225
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
BMJ. 2020 Apr 8;369:m1403
pubmed: 32269032
Implement Sci. 2013 Feb 13;8:18
pubmed: 23406398
Sci Data. 2020 Oct 8;7(1):345
pubmed: 33033256

Auteurs

Anne-Marie Martindale (AM)

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England. a.martindale@liverpool.ac.uk.

Caitlin Pilbeam (C)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England.

Hayley Mableson (H)

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England.

Sarah Tonkin-Crine (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England.

Paul Atkinson (P)

Institute of Population Health, University of Liverpool, Liverpool, England.

Aleksandra Borek (A)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England.

Suzannah Lant (S)

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England.

Nina Gobat (N)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England.

Tom Solomon (T)

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England.

Sally Sheard (S)

Institute of Population Health, University of Liverpool, Liverpool, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH